ProPhase Labs Announces Pricing of Public Offering of Common Stock
November 07, 2024 23:37 ET
|
ProPhase Labs, Inc.
GARDEN CITY, NY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and diagnostics company, today announced the...
PAVmed Closes Additional $8.1 Million Common Stock Registered Direct Offering
December 22, 2020 12:04 ET
|
PAVmed Inc.
NEW YORK, Dec. 22, 2020 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical device company, today...